Table 3.

Changes in Individual Functioning During Treatment and Follow-up

	Full Sample						Participants Experiencing Initial Problemsa
	b	95% CI	t-ratio	df	p- value	Within- group d	b	95% CI	t-ratio	df	p-value	Within- group d
Depression Symptoms - CESD
Treatment	−0.495	[−0.596, −0.384]	−9.044	149	<0.001	−0.61	−1.140	[−1.316, −0.964]	−12.689	78	<0.001	−2.06
Follow-up	−0.002	[−0.014, 0.010]	−0.397	149	0.692	0.04	−0.004	[−0.027, 0.019]	−0.371	78	0.711	−0.06
Anxiety Symptoms – GAD7
Treatment	−0.435	[−0.523, −0.347]	−9.702	149	<0.001	−0.57	−0.837	[−1.002, −0.672]	−9.936	81	<0.001	−1.73
Follow-up	−0.015	[−0.026, −0.004]	−2.703	149	0.008	−0.12	−0.017	[−0.040, 0.006]	−1.402	81	0.163	−0.28
Work Functioning
Treatment	0.032	[0.015, 0.049]	3.635	149	<0.001	0.23	0.133	[0.106, 0.160]	9.514	85	<0.001	1.59
Follow-up	0.001	[−0.002, 0.004]	1.004	149	0.298	0.07	0.003	[−0.002, 0.008]	1.353	85	0.178	0.28
Quality of Life
Treatment	0.093	[0.074, 0.112]	9.848	149	<0.001	0.67	0.152	[0.130, 0.174]	13.877	114	<0.001	1.69
Follow-up	0.001	[−0.001, 0.003]	1.233	149	0.220	0.07	0.002b	[−0.001, 0.005]	1.523	114	0.130	0.17
Perceived Health
Treatment	0.033	[0.016, 0.050]	3.820	149	<0.001	0.31	0.088	[0.067, 0.109]	8.149	112	<0.001	0.97
Follow-up	−0.001	[−0.004, 0.002]	−0.751	149	0.454	−0.10	0.004	[0.000, 0.008]	1.943	112	0.054	0.35

Note: “Follow-up” represents change that occurred from the end of treatment through the 1-year follow-up assessment.

^aIndividuals who were categorized in the clinical or problematic range at the beginning of the intervention; see text for cutoffs used for each construct.

^bThere was a significant follow-up X gender interaction where men deteriorated significantly more than women over follow-up [b = 0.007 (0.001, 0.013), p = 0.030].